Clinical experience with tocilizumab in the treatment of pregnant woman with severe COVID-19
The aim of the work – to present a case of positive use of tocilizumab in the treatment of pregnant woman with severe COVID-19. Materials and methods. A self-observation clinical case of severe coronavirus disease (COVID-19) in pregnant K., 40 years old, who was treated at Municipal Non-Profit En...
Saved in:
| Main Authors: | O. V. Riabokon, I. O. Kuliesh, O. O. Furyk, T. B. Matvieieva, K. V. Kalashnyk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2022-06-01
|
| Series: | Patologìâ |
| Subjects: | |
| Online Access: | http://pat.zsmu.edu.ua/article/view/253286/254980 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case of severe COVID-19 and influenza co-infection
by: O. V. Riabokon, et al.
Published: (2023-10-01) -
Sarilumab is not Inferior to Tocilizumab in the Treatment of Cytokine Release Syndrome in COVID-19
by: V. T. Ivashkin, et al.
Published: (2023-12-01) -
Predictive value of the Elixhauser comorbidity index in assessing the risk of coronavirus disease (COVID-19) mortality in patients with pneumonia
by: I. O. Kuliesh, et al.
Published: (2025-02-01) -
EXPERIENCE WITH TOCILIZUMAB, AN INTERLEUKIN 6 INHIBITOR, USED FOR THE TREATMENT OF GIANT CELL ARTERITIS WITH SEVERE COMORBIDITY
by: T. V. Beketova, et al.
Published: (2018-05-01) -
The use of different formulations of tocilizumab in the treatment of patients with moderate to severe COVID-19
by: E. I. Veselova, et al.
Published: (2021-02-01)